INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• How Modern EDC Systems Are Becoming Clinical Intelligence Hubs

  Modern electronic data capture (EDC) systems are transforming clinical trials by evolving from data repositories into dynamic clinical intelligence hubs.

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Maintain Compliance Through Divestiture Without Disrupting Operations

  Facing a divestiture? Learn how to protect historical quality records and stay audit-ready throughout the transition. 

• Top 10 HEOR Trends Report

  Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

• The Trust Deficit: Is An Overlooked Literacy Gap Stalling Clinical Trial Enrollment?

  11/7/2025

  Here, we examine the critical disconnect in a patient's understanding and how purpose-built AI platforms can translate complex medical language into plain, accessible communication.

• What AI Replaces In Phase 2/3 Data Management

  5/6/2026

  Explore how clinical teams are moving beyond AI hype to implement grounded strategies for automated edit checks, risk-based query management, and the regulatory frameworks needed for oversight.

• At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights

  5/20/2025

  Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

• Navigating The Enrollment Bottleneck In Early Oncology Trials

  1/12/2026

  Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

• Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  9/16/2024

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.